Figure legends
Figure 1. Currently investigated drugs in COVID-19 grouped according to their clinical use
Figure 2. Skin manifestations similar to those in other viral infections. A. Urticaria (23), B. Morbilliform maculopapular exanthem (24), C. Vesiculopapular (chickenpox-like) exanthem (26), D. Intertriginous purpuric rash (27)
Figure 3. Skin manifestations associated with thrombovascular events and vascular pathologies. A. Transient unilateral livedo reticularis (erythema ab igne) (31), B. COVID-19-induced chilblains (32), C. Acro-ischemia with cyanosis, skin bulla, and dry gangrene in critically ill patient (35)